Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Microbix Biosystems stock price, quote, forecast and news

MBX.TO
CA59501P1045
935162

Price

0.34
Today +/-
-0.00
Today %
-1.46 %
P

Microbix Biosystems stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Microbix Biosystems stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Microbix Biosystems stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Microbix Biosystems stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Microbix Biosystems's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Microbix Biosystems Stock Price History

DateMicrobix Biosystems Price
9/20/20240.34 undefined
9/19/20240.35 undefined
9/18/20240.35 undefined
9/17/20240.34 undefined
9/16/20240.35 undefined
9/13/20240.35 undefined
9/12/20240.35 undefined
9/11/20240.36 undefined
9/10/20240.36 undefined
9/9/20240.36 undefined
9/6/20240.38 undefined
9/5/20240.37 undefined
9/4/20240.38 undefined
9/3/20240.38 undefined
8/30/20240.38 undefined
8/29/20240.38 undefined
8/28/20240.38 undefined
8/27/20240.37 undefined
8/26/20240.36 undefined
8/23/20240.36 undefined

Microbix Biosystems Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Microbix Biosystems, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Microbix Biosystems from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Microbix Biosystems’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Microbix Biosystems. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Microbix Biosystems’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Microbix Biosystems’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Microbix Biosystems’s growth potential.

Microbix Biosystems Revenue, EBIT and net profit per share

DateMicrobix Biosystems RevenueMicrobix Biosystems EBITMicrobix Biosystems Net Income
2026e39.59 M undefined17.47 M undefined6.89 M undefined
2025e29.39 M undefined9.81 M undefined2.76 M undefined
2024e25.45 M undefined8.16 M undefined2.76 M undefined
202316.51 M undefined-2.74 M undefined-40,000 undefined
202219.08 M undefined2.61 M undefined1.79 M undefined
202118.59 M undefined4.82 M undefined3.23 M undefined
202010.52 M undefined-560,000 undefined-6.23 M undefined
201913.41 M undefined1.03 M undefined30,000 undefined
201812.51 M undefined80,000 undefined-740,000 undefined
201710.19 M undefined-650,000 undefined-3.78 M undefined
20169.52 M undefined830,000 undefined750,000 undefined
20158.87 M undefined1.09 M undefined610,000 undefined
20148.4 M undefined1.31 M undefined170,000 undefined
20137.57 M undefined730,000 undefined0 undefined
20126.67 M undefined-1.69 M undefined-2.39 M undefined
20116.23 M undefined-1.66 M undefined-2.57 M undefined
20106.46 M undefined-1.65 M undefined-2.54 M undefined
20096.08 M undefined-1.9 M undefined-2.48 M undefined
20084.99 M undefined-3.49 M undefined-3.67 M undefined
20074.05 M undefined-2.34 M undefined-2.71 M undefined
20063.65 M undefined-1.9 M undefined-2.09 M undefined
20054.38 M undefined300,000 undefined120,000 undefined
20044.07 M undefined90,000 undefined10,000 undefined

Microbix Biosystems Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
2311222443446666788910121310181916252939
-50.00-66.67-100.00--100.00--25.0033.33-50.00---16.6714.29-12.5011.1120.008.33-23.0880.005.56-15.7956.2516.0034.48
50.00-100.00100.00100.0050.0050.0050.0050.0033.3325.0050.0050.0050.0033.3333.3342.8650.0062.5044.4440.0041.6746.1540.0061.1157.8943.75---
10112112211233223454456411117000
0-2-4000000-1-2-3-1-1-1-10110001042-28917
--66.67-400.00-------33.33-50.00-75.00-16.67-16.67-16.67-16.67-12.5012.50---7.69-22.2210.53-12.5032.0031.0343.59
0-2-4000000-2-2-3-2-2-2-20000-300-6310226
--100.00--------50.00-33.33------------150.00-66.67---200.00
32.3233.6733.6833.9234.5734.4834.4935.293635.1236.845.5446.4548.6354.8461.9366.668.9880.8784.7184.796.297.09104.84141.68135.38137.91000
------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Microbix Biosystems Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Microbix Biosystems is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (M)OTHER CURRENT LIAB. (k)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (k)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (k)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                     
6.141.680.220.550.690.560.531.271.260.40.643.410.590.020.130.230.260.550.10.010.050.040.10.099.9913.4911.61
0.721.080.370.450.450.470.740.320.360.310.630.851.021.851.41.451.152.141.692.021.341.311.711.884.183.064.12
470470000305014014032019036010013010060801501501801501007010303060
0.583.080.440.410.390.430.450.490.560.840.760.870.931.091.281.251.071.63.633.44.474.454.484.294.415.285.75
130806050903050508070801301101001801508028022060150170100220500550770
8.046.391.091.461.621.521.822.272.41.942.35.622.753.193.093.142.644.725.795.676.166.076.466.4919.1122.4122.31
0.781.821.521.371.291.181.151.121.281.751.834.636.86.696.386.135.938.7511.8712.2512.216.656.657.368.088.918.93
000000000000000000000000000
00000000000000000000000030310
000000000.280.261.684.364.284.194.093.993.94.055.366.26.485.024.961.741.651.54.42
000000000000000000000000000
0.240.170.120.080.040.020.020.0100000.250.250.250.250.250.490.531.131.581.581.57000.330
1.021.991.641.451.331.21.171.131.562.013.518.9911.3311.1310.7210.3710.0813.2917.7619.5820.2713.2513.189.19.7610.7713.35
9.068.382.732.912.952.722.993.43.963.955.8114.6114.0814.3213.8113.5112.7218.0123.5525.2526.4319.3219.6415.5928.8733.1835.66
                                                     
7.548.078.078.548.588.588.598.598.848.9211.918.819.4220.722.4224.0324.327.6630.9931.331.333.9133.9135.3643.6149.9249.04
0000000.010.030.760.971.131.412.072.562.963.343.554.494.384.948.059.249.3910.2510.79.6210.22
410-1,680-6,330-6,780-6,530-6,460-6,830-6,810-7,300-9,390-12,100-15,770-18,250-20,790-23,310-25,950-24,830-24,660-24,050-23,300-27,080-35,700-35,670-41,890-38,660-36,870-36,910
0.06000000.220.470.470.971.353.173.173.172.72.72.72.352.352.352.92.92.92.92.92.272.27
000000000000000000000000000
8.016.391.741.762.052.121.992.282.771.472.287.616.415.644.774.125.729.8413.6715.2915.1710.3510.536.6218.5524.9424.62
0.531.170.380.390.350.260.560.460.510.950.852.231.581.922.081.911.351.832.491.92.841.771.461.491.791.832.08
000000000000000000000000000
0.070.07000000000000.210.050.14000.190.681.150.930.641.320.740.552
00000000000000.260.130.49000000.261.40000
0.450.150.150.450.410.30.140.060.020.080.090.030.080.140.140.120.610.811.462.672.531.21.261.292.660.270.27
1.051.390.530.840.760.560.70.520.531.030.942.261.662.532.42.661.962.644.145.256.524.164.764.15.192.654.35
00.60.450.30.150.050.290.560.621.211.853.875.495.66.16.34.615.15.734.714.754.84.334.895.085.566.38
000000000000000000000000000
0000000303024073085052053054041041041000000000300
00.60.450.30.150.050.290.590.651.452.584.726.016.136.646.715.025.515.734.714.754.84.334.895.085.566.68
1.051.990.981.140.910.610.991.111.182.483.526.987.678.669.049.376.988.159.879.9611.278.969.098.9910.278.2111.03
9.068.382.722.92.962.732.983.393.953.955.814.5914.0814.313.8113.4912.717.9923.5425.2526.4419.3119.6215.6128.8233.1535.65
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Microbix Biosystems provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Microbix Biosystems's financial health and stability.

Assets

Microbix Biosystems's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Microbix Biosystems must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Microbix Biosystems after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Microbix Biosystems's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (k)DEFERRED TAXES (k)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (k)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0-2-4000000-2-2-3-2-2-2-20000-3-80-6310
00000000000000000000000001,0001,000
000000000000000000000001,000000
0-2300000000000000-1000-100-300
00000000000000000000380310-1
000000000000000000000000000
000000000000000000000000000
0-3-1000000-1-1-1-2-1-1-10-100000023-1
0-1000000000-3-20000-3-4-10-100-1-2-1
0-1000000000-5-20000-3-4-10-1000-2-1
00000000000-2000000000000000
000000000000000000000000000
000000000003100000100-10-10-11
60000000001601110320030283-1
6000000000210211104300100820
000000000000000001,000000000000
000000000000000000000000000
5-4-1000000002-20000000000093-1
-0.56-5.23-1.31-0.130.290.08-0.310.340.13-1.84-2.02-5.01-4.99-1.96-1.36-1.830.2-4.55-4.24-0.73-0.34-1.76-0.47-0.80.871.44-2.11
000000000000000000000000000

Microbix Biosystems stock margins

The Microbix Biosystems margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Microbix Biosystems. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Microbix Biosystems.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Microbix Biosystems's sales revenue. A higher gross margin percentage indicates that the Microbix Biosystems retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Microbix Biosystems's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Microbix Biosystems's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Microbix Biosystems's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Microbix Biosystems. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Microbix Biosystems's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Microbix Biosystems Margin History

Microbix Biosystems Gross marginMicrobix Biosystems Profit marginMicrobix Biosystems EBIT marginMicrobix Biosystems Profit margin
2026e45.31 %44.13 %17.4 %
2025e45.31 %33.37 %9.38 %
2024e45.31 %32.07 %10.83 %
202345.31 %-16.6 %-0.24 %
202258.28 %13.68 %9.38 %
202159.39 %25.93 %17.37 %
202044.3 %-5.32 %-59.22 %
201948.84 %7.68 %0.22 %
201842.93 %0.64 %-5.92 %
201747.2 %-6.38 %-37.1 %
201652.31 %8.72 %7.88 %
201565.84 %12.29 %6.88 %
201453.69 %15.6 %2.02 %
201350.59 %9.64 %0 %
201241.23 %-25.34 %-35.83 %
201144.94 %-26.65 %-41.25 %
201057.74 %-25.54 %-39.32 %
200958.55 %-31.25 %-40.79 %
200850.3 %-69.94 %-73.55 %
200747.65 %-57.78 %-66.91 %
200651.78 %-52.05 %-57.26 %
200561.64 %6.85 %2.74 %
200463.39 %2.21 %0.25 %

Microbix Biosystems Stock Sales Revenue, EBIT, Earnings per Share

The Microbix Biosystems earnings per share therefore indicates how much revenue Microbix Biosystems has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Microbix Biosystems earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Microbix Biosystems's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Microbix Biosystems’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Microbix Biosystems's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Microbix Biosystems Revenue, EBIT and net profit per share

DateMicrobix Biosystems Sales per ShareMicrobix Biosystems EBIT per shareMicrobix Biosystems Earnings per Share
2026e0.29 undefined0 undefined0.05 undefined
2025e0.22 undefined0 undefined0.02 undefined
2024e0.19 undefined0 undefined0.02 undefined
20230.12 undefined-0.02 undefined-0 undefined
20220.14 undefined0.02 undefined0.01 undefined
20210.13 undefined0.03 undefined0.02 undefined
20200.1 undefined-0.01 undefined-0.06 undefined
20190.14 undefined0.01 undefined0 undefined
20180.13 undefined0 undefined-0.01 undefined
20170.12 undefined-0.01 undefined-0.04 undefined
20160.11 undefined0.01 undefined0.01 undefined
20150.11 undefined0.01 undefined0.01 undefined
20140.12 undefined0.02 undefined0 undefined
20130.11 undefined0.01 undefined0 undefined
20120.11 undefined-0.03 undefined-0.04 undefined
20110.11 undefined-0.03 undefined-0.05 undefined
20100.13 undefined-0.03 undefined-0.05 undefined
20090.13 undefined-0.04 undefined-0.05 undefined
20080.11 undefined-0.08 undefined-0.08 undefined
20070.11 undefined-0.06 undefined-0.07 undefined
20060.1 undefined-0.05 undefined-0.06 undefined
20050.12 undefined0.01 undefined0 undefined
20040.12 undefined0 undefined0 undefined

Microbix Biosystems business model

Microbix Biosystems Inc. is a Canadian company specializing in the development and marketing of biological products and solutions in various industries. The company was founded in 1988 and is headquartered in Toronto, Ontario. Microbix Biosystems is one of the most popular companies on Eulerpool.com.

Microbix Biosystems SWOT Analysis

Strengths

Microbix Biosystems Inc boasts a strong portfolio of proprietary technologies and intellectual property, including its viral antigen production capabilities.

The company has established itself as a leader in the development and manufacture of critical biological products used in diagnostics, quality control, and research.

Microbix has a diverse range of end markets and customers, reducing dependency on any single sector or client.

Weaknesses

The company heavily relies on key customers for a significant portion of its revenue, which may present business continuity risks in case of customer departure.

Microbix faces competition from both established players and emerging companies in the biotherapeutics and diagnostics markets.

Limited financial resources may hamper the company's ability to invest in research and development and expand its operations.

Opportunities

The increasing demand for biopharmaceutical products and diagnostic solutions presents significant growth opportunities for Microbix Biosystems Inc.

Expanding into new geographic markets and strategic partnerships with leading industry players can help the company to strengthen its market position.

Leveraging its expertise in viral antigen production, Microbix can explore opportunities in vaccine development, particularly amid the current global health concerns.

Threats

Rapidly changing market dynamics and regulatory requirements could impact the company's ability to adapt and stay competitive.

Economic downturns or global crises may lead to reduced demand for the company's products and services.

The entry of new competitors with disruptive technologies and lower cost structures poses a threat to Microbix's market share and profitability.

Microbix Biosystems Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Microbix Biosystems historical P/E ratio, EBIT, and P/S ratio.

Microbix Biosystems shares outstanding

The number of shares was Microbix Biosystems in 2023 — This indicates how many shares 137.91 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Microbix Biosystems earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Microbix Biosystems's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Microbix Biosystems’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Microbix Biosystems's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Microbix Biosystems.

Microbix Biosystems latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/2023-0 0.04  (3,600 %)2023 Q4
6/30/20230 -0.01  (0 %)2023 Q3
3/31/2023-0 0  (100 %)2023 Q2
12/31/20220 -0.01  (-700 %)2023 Q1
9/30/20220 -0.01  (-460 %)2022 Q4
6/30/20220.01 0  (-21.57 %)2022 Q3
3/31/20220.01 0.01  (-58.68 %)2022 Q2
12/31/20210.01 0.01  (-40.59 %)2022 Q1
9/30/20210.01 0.01  (9.89 %)2021 Q4
6/30/20210.01 0.01  (54.93 %)2021 Q3
1
2

Microbix Biosystems list of shareholders

%
Name
Stocks
Change
Date
6.91912 % Renner (Joseph D)9,440,037100,0002/21/2024
2.19923 % Groome (Cameron L)3,000,500-119,5002/21/2024
2.06288 % Blecher (Peter M)2,814,47402/13/2024
1.25827 % Embro-Pantalony (Vaughn C)1,716,704100,0002/13/2024
1.07500 % Marino (Martin)1,466,66702/13/2024
0.42475 % LDIC Inc.579,500-677,5006/30/2023
0.40260 % Cochran (Mark A)549,27702/13/2024
0.36669 % Microbix Biosystems Inc.500,288377,2143/28/2024
0.20156 % Currie (James Stuart)275,00094,5001/17/2024
0.16125 % Costa (Daniel Oliveira)220,000220,0001/17/2024
1
2

Most common questions regarding Microbix Biosystems

What values and corporate philosophy does Microbix Biosystems represent?

Microbix Biosystems Inc represents the values of exceptional innovation, dedication to quality, and commitment to customer satisfaction. As a leading biotechnology company, Microbix is driven by a strong corporate philosophy centered on advancing human health through the development and production of high-quality diagnostic reagents and viral antigens. With a focus on continuous improvement, Microbix strives to deliver superior products and services to meet the evolving needs of the healthcare industry. By prioritizing research and development, along with stringent quality control measures, Microbix Biosystems Inc ensures its reputation as a trusted provider of essential biological products.

In which countries and regions is Microbix Biosystems primarily present?

Microbix Biosystems Inc is primarily present in Canada, United States, Europe, and Asia.

What significant milestones has the company Microbix Biosystems achieved?

Microbix Biosystems Inc, a leading life science company, has accomplished several significant milestones. Notably, the company successfully developed and launched key products in the virology industry, including Quality Assessment (QA) controls for viral diseases and viral antigens. Microbix Biosystems Inc also introduced innovative technologies like the Kinlytic Urokinase, a clot-dissolving agent. Through strategic partnerships, the company expanded its global presence and garnered recognition for its exceptional research and development capabilities. Furthermore, Microbix Biosystems Inc achieved ISO 13485 certification, validating its commitment to quality management systems. These achievements solidify the company's position as a prominent player in the biotechnology sector.

What is the history and background of the company Microbix Biosystems?

Microbix Biosystems Inc is a well-established company with a rich history and background. Founded in 1988, Microbix has grown to become a leading provider of biological products and technologies worldwide. The company specializes in the development, manufacture, and distribution of biological materials used in the diagnostics, research, and quality control fields. With its state-of-the-art facilities and dedicated team of experts, Microbix has consistently delivered innovative solutions to the global life sciences industry. Their wide range of products and services includes viral antigens, quality assessment programs, and proficiency panels. Throughout its history, Microbix Biosystems Inc has remained committed to providing high-quality products and contributing to advancements in the healthcare sector.

Who are the main competitors of Microbix Biosystems in the market?

The main competitors of Microbix Biosystems Inc in the market include companies such as Becton, Dickinson and Company (BD), Bio-Rad Laboratories, and Meridian Bioscience Inc.

In which industries is Microbix Biosystems primarily active?

Microbix Biosystems Inc is primarily active in the fields of virology and molecular diagnostics.

What is the business model of Microbix Biosystems?

Microbix Biosystems Inc is a leading biotechnology company with a robust business model focused on developing and commercializing innovative biological products. The company specializes in producing and marketing unique biological substances, such as antigens and quality assessment controls, for diagnostic testing and scientific research. Microbix Biosystems Inc leverages its extensive expertise in virology, immunology, and bioprocessing to provide high-quality products to diagnostic laboratories, biopharmaceutical companies, and research institutions worldwide. With a continued commitment to advancing healthcare and scientific research, Microbix Biosystems Inc has established a strong reputation as a trusted partner in the industry.

What is the P/E ratio of Microbix Biosystems 2024?

The Microbix Biosystems P/E ratio is 17.01.

What is the P/S ratio of Microbix Biosystems 2024?

The Microbix Biosystems P/S ratio is 1.84.

What is the AlleAktien quality score of Microbix Biosystems?

The AlleAktien quality score for Microbix Biosystems is 5/10.

What is the revenue of Microbix Biosystems 2024?

The expected Microbix Biosystems revenue is 25.45 M CAD.

How high is the profit of Microbix Biosystems 2024?

The expected Microbix Biosystems profit is 2.76 M CAD.

What is the business model of Microbix Biosystems

Microbix Biosystems Inc is a Toronto-based biotechnology company that focuses on researching, developing, and marketing diagnostic and therapeutic products. The company operates in three business areas: Diagnostic test systems, infectious diseases, and bioproducts.

What is the Microbix Biosystems dividend?

Microbix Biosystems pays a dividend of 0 CAD distributed over payouts per year.

How often does Microbix Biosystems pay dividends?

The dividend cannot currently be calculated for Microbix Biosystems or the company does not pay out a dividend.

What is the Microbix Biosystems ISIN?

The ISIN of Microbix Biosystems is CA59501P1045.

What is the Microbix Biosystems WKN?

The WKN of Microbix Biosystems is 935162.

What is the Microbix Biosystems ticker?

The ticker of Microbix Biosystems is MBX.TO.

How much dividend does Microbix Biosystems pay?

Over the past 12 months, Microbix Biosystems paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Microbix Biosystems is expected to pay a dividend of 0 CAD.

What is the dividend yield of Microbix Biosystems?

The current dividend yield of Microbix Biosystems is .

When does Microbix Biosystems pay dividends?

Microbix Biosystems pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Microbix Biosystems?

Microbix Biosystems paid dividends every year for the past 0 years.

What is the dividend of Microbix Biosystems?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Microbix Biosystems located?

Microbix Biosystems is assigned to the 'Health' sector.

Wann musste ich die Aktien von Microbix Biosystems kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Microbix Biosystems from 9/21/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 9/21/2024.

When did Microbix Biosystems pay the last dividend?

The last dividend was paid out on 9/21/2024.

What was the dividend of Microbix Biosystems in the year 2023?

In the year 2023, Microbix Biosystems distributed 0 CAD as dividends.

In which currency does Microbix Biosystems pay out the dividend?

The dividends of Microbix Biosystems are distributed in CAD.

All fundamentals about Microbix Biosystems

Our stock analysis for Microbix Biosystems Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Microbix Biosystems Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.